XML 99 R74.htm IDEA: XBRL DOCUMENT v3.20.1
Note 6 - Personnel Expenses Including Share-based Remuneration (Details Textual)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jan. 01, 2020
$ / shares
Jan. 10, 2019
shares
Statement Line Items [Line Items]          
Key management personnel compensation, share-based payment | $ $ 536 $ 621 $ 0    
Payables on social security and taxes other than income tax | $ 1,050        
Share-based payment arrangement, social security on options grants payable | $ $ 1,442        
Major ordinary share transactions [member]          
Statement Line Items [Line Items]          
Number of other equity instruments exercisable in share-based payment arrangement       1,130,000  
Number of share options exercisable in share-based payment arrangement       30,000  
Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement (in dollars per share) | $ / shares       $ 0  
Weighted average exercise price of share options exercisable in share-based payment arrangement (in dollars per share) | $ / shares       $ 7.42  
RSU [member]          
Statement Line Items [Line Items]          
Percentage of equity available for grants 10.00%        
Number of shares in ultimate issure entity (in shares) 500,000,000        
Number of shares set up with parent company for share-based payments arrangement (in shares) 200,000,000        
Conversion ratio from the count of RSUs granted to ultimate shares to be delivered 0.4        
Number of shares represented by ADS (in shares) 2        
Adjustment factor for reported grants in a share-based payments arrangment 0.5        
Share-based payments arrangement, vesting schedule, in year one 16.00%        
Share-based payments arrangement, vesting schedule, in year two 22.00%        
Share-based payments arrangement, vesting schedule, in yearthree 28.00%        
Share-based payments arrangement, vesting schedule, in year four 34.00%        
Weighted average remaining contractual life of outstanding other equity instruments 0.95 0.97      
Amended and restated share incentive plan [member]          
Statement Line Items [Line Items]          
Number of shares reserved for issue under options and contracts for sale of shares (in shares)         20,000,000
Amended and restated share incentive plan [member] | ADS [member]          
Statement Line Items [Line Items]          
Number of shares reserved for issue under options and contracts for sale of shares (in shares)         10,000,000